SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLTAN, Rebecca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.366
AS - Asia 2.863
EU - Europa 2.292
SA - Sud America 559
AF - Africa 71
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.259
SG - Singapore 1.147
CN - Cina 798
IT - Italia 724
BR - Brasile 475
DE - Germania 366
PL - Polonia 283
HK - Hong Kong 274
UA - Ucraina 232
GB - Regno Unito 204
VN - Vietnam 199
TR - Turchia 190
FI - Finlandia 105
RU - Federazione Russa 82
SE - Svezia 67
ID - Indonesia 66
CA - Canada 57
NL - Olanda 52
FR - Francia 44
IN - India 41
MX - Messico 41
AR - Argentina 36
JP - Giappone 33
ZA - Sudafrica 31
BD - Bangladesh 21
ES - Italia 20
LT - Lituania 19
CZ - Repubblica Ceca 17
BE - Belgio 14
EC - Ecuador 13
EE - Estonia 13
AT - Austria 11
IQ - Iraq 11
PK - Pakistan 11
DZ - Algeria 9
KR - Corea 9
CL - Cile 8
IE - Irlanda 8
UZ - Uzbekistan 8
CO - Colombia 7
RO - Romania 7
TN - Tunisia 7
VE - Venezuela 7
IR - Iran 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
CY - Cipro 5
KE - Kenya 5
PY - Paraguay 5
TW - Taiwan 5
AU - Australia 4
JO - Giordania 4
PE - Perù 4
BG - Bulgaria 3
CH - Svizzera 3
EG - Egitto 3
GE - Georgia 3
IL - Israele 3
KG - Kirghizistan 3
NI - Nicaragua 3
OM - Oman 3
SA - Arabia Saudita 3
TZ - Tanzania 3
UY - Uruguay 3
CR - Costa Rica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MC - Monaco 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
Totale 12.157
Salva come PNG Salva come JPEG
Città #
Fairfield 722
Ashburn 708
Singapore 643
Woodbridge 603
Houston 403
Beijing 325
Chandler 303
Seattle 291
Ferrara 281
Ann Arbor 279
Warsaw 277
Hong Kong 271
Santa Clara 270
Cambridge 268
Jacksonville 268
Wilmington 247
Dallas 243
Los Angeles 123
Munich 122
New York 106
Izmir 89
Nanjing 82
Boardman 73
Princeton 61
Milan 60
Ho Chi Minh City 58
Jakarta 57
Bologna 48
São Paulo 47
Turku 47
San Diego 46
Shanghai 45
London 36
Hanoi 32
Brooklyn 30
Poplar 30
Dong Ket 29
Mexico City 28
Falls Church 27
Denver 26
Buffalo 25
Chicago 25
The Dalles 25
Tokyo 25
Bremen 24
Johannesburg 24
Rome 23
Nanchang 22
Shenyang 20
Toronto 20
Boston 19
Mersin 19
Frankfurt am Main 18
Hebei 18
Montreal 18
Istanbul 17
Rio de Janeiro 17
Dearborn 16
Hefei 16
Brno 15
Phoenix 15
Brussels 14
Changsha 14
Chennai 14
Orem 14
Atlanta 13
Norwalk 13
Tallinn 13
Tianjin 13
Brasília 12
Council Bluffs 12
Kunming 12
San Francisco 12
Washington 12
Ankara 11
Moscow 11
Nuremberg 11
Jiaxing 10
Stockholm 10
Florence 9
Helsinki 9
Manchester 9
Mountain View 9
New Delhi 9
Orange 9
Parma 9
Tappahannock 9
Turin 9
Auburn Hills 8
Curitiba 8
Da Nang 8
Guangzhou 8
Naples 8
Redwood City 8
Tashkent 8
Amsterdam 7
Augusta 7
Columbus 7
Haiphong 7
Hải Dương 7
Totale 8.518
Salva come PNG Salva come JPEG
Nome #
Netter's Introduzione all'imaging 290
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 260
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 243
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 236
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 230
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 222
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 219
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 215
Antitumoral activity of Asparagus officinalis extracts against breast cancer 211
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 209
Anticancer Activity of Aqueous Extracts from Asparagus officinalis L. Byproduct on Breast Cancer Cells 208
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 201
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 201
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 195
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 195
Actively targeted nanocarriers for drug delivery to cancer cells 193
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 191
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 189
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 189
Clinical perspectives of TRAIL: Insights into central nervous system disorders 186
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 177
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 176
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 175
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 175
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 171
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 165
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 164
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 150
SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase 149
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 148
Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders 145
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. 144
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 143
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 135
Live recombinant vectors for AIDS vaccine development 134
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 133
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication 131
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 131
Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples 130
Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity 129
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents 129
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 127
p53 and merlin tumor suppressors: Two of a kind 120
In Vitro Skin sensitisation analysis by the U-SENS method for new molecules innovative materials and medical devices 117
In-vitro anticancer activity of Asparagus officinalis extracts on breast carcinoma 116
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes 113
Asparagus officinalis L. aqueous extracts mediate cell cycle block and migration inhibition in breast cancer cells 109
Nutlin-3a-loaded ethosomes as an efficient nanodelivery system target p53 in melanoma 105
ACE2 up-regulation by MDM2 inhibition reduces inflammation and monocytes adhesion in HUVEC 105
null 103
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 102
null 101
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells 100
null 100
Nutlin-3 Loaded Ethosomes and Transethosomes to Prevent UV-Associated Skin Damage 98
null 97
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 97
null 94
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 94
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 93
null 92
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 91
In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure 91
null 90
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin 90
null 90
Ethosomes nanodelivery of the MDM2 inhibitor Nutlin-3a efficiently induces cells death in melanoma 89
Effects of Nutlin-3a on endothelial cells in the presence of inflammation 89
null 89
null 88
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 87
null 86
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 86
null 86
null 84
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 83
null 83
MDM2 inhibitors counteract inflammation by stabilization of ACE2 in vitro 82
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 82
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection 81
null 81
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 80
Cell cycle block by p53 activation reduces SARS-CoV-2 release in A549-hAce2 cells 78
null 74
Role of miRNA in adult ocular tumorigenesis 68
Nanoparticles engineered with Rituximab and loaded with Nutlin-3 show promising therapeutic activity in B leukemic xenografts 68
Use of bioactives from agrifood by-products in topical cosmetic hydrogels 66
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 65
Nutlin-3a-loaded ethosomes as a delivery system in vitro to Target p53 in melanoma 62
Oscillatory turbulent flow in chronic venous disease induces pro-inflammatory and reparative biological signaling 61
null 55
MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma 54
Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration 54
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 47
State of the art of the therapeutic perspective of sorafenib against hematological malignancies 46
Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation 43
null 43
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 43
null 42
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 39
Totale 12.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.288
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021874 0 0 0 0 0 139 93 136 58 238 131 79
2021/2022719 25 75 57 37 89 45 44 28 31 54 71 163
2022/2023767 66 48 32 91 108 98 35 66 99 32 56 36
2023/2024544 57 43 20 15 29 74 21 58 17 16 42 152
2024/20252.332 62 75 174 121 296 201 126 130 380 185 301 281
2025/20263.402 579 383 532 765 857 286 0 0 0 0 0 0
Totale 12.368